News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Monsanto Company (MON) And TwistDx Begin Field Trials of Rapid Diagnostic Tests for More Efficient Delivery of Biotech Crops



8/4/2009 9:45:20 AM

CAMBRIDGE, England--(BUSINESS WIRE)--TwistDx, a developer of point-of-use nucleic acid diagnostics, announced today that they have made strong progress toward developing rapid, DNA-based field tests with Monsanto Company (NYSE:MON). Monsanto plans to use the tests to enhance the efficiency with which biotechnology crops are delivered across the globe.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES